We compared an FDA cleared molecular meningitis/encephalitis panel to lab developed viral PCRs and bacterial culture. Of the 67 viral PCR or bacterial culture-positive samples, 92.5% were positive for the same target by the panel. Of the 66 negative samples tested, no targets were detected by the panel, for an agreement of 96.2%.
Keywords: Encephalitis; Meningitis; Molecular Panel.
Copyright © 2016 Elsevier Inc. All rights reserved.